P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.

• F Fazio,
• A Di Rocco,
• T Za,
• V Tomarchio,
• A Rago,
• A Piciocchi,
• T Caravita di Toritto,
• O Annibali,
• V De Stefano,
• R Foà,
• M Martelli,
• MT Petrucci

Affiliations

F Fazio

1 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome

A Di Rocco

1 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome

T Za

2 Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli, IRCCS; Rome

V Tomarchio

3 Unit of Hematology, Stem Cell Transplantation, University Campus Bio Medico, Rome

A Rago

4 UOSD Ematologia ASL Roma, Rome

A Piciocchi

5 Italian Group For Adult Hematologic Diseases (GIMEMA), Rome

T Caravita di Toritto

4 UOSD Ematologia ASL Roma, Rome

O Annibali

2 Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli, IRCCS; Rome

V De Stefano

2 Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli, IRCCS; Rome

R Foà

1 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome

M Martelli

1 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome

MT Petrucci

1 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome